
Secured Loan Note update
Posted on: Friday, July 24, 2009Meldex announces that the amount raised up to 22 July 2009 through the Secured Loan Note (“SLN”) offering was £1,455,000. The directors announced on 22 July 2009 the extension of the offering through to 11 August 2009.
The Company has tried to minimise dilution of existing Shareholders through the proposed conversion price of any convertible loan notes offered in substitution for the Loan Notes. However, as subscriptions have so far fallen short of the minimum amount required under the SLN offering, the Company considers it prudent to reduce the price of the proposed conversion in order to seek to ensure the success of the SLN offering.
Therefore, the directors intend, as soon as reasonably practicable following the completion of the SLN offering, to call a General Meeting of Members at which a resolution will be put to Members to increase the ordinary share capital by an amount sufficient to allow the conversion of any convertible loan note offered in substitution for the SLN into ordinary shares at a conversion price of 2p per share. The circular that was sent to shareholders on or around 25 June 2009 had referred to a proposed conversion price of 10p per share.
Any Qualifying Shareholder who has not received a copy of the SLN documentation or who would like another application form should contact the Company by calling 01223 394250 or by sending an email to BJM@meldexinternational.com.
Shareholders who have already subscribed in the SLN offering may complete an additional application form if they wish to subscribe for further secured loan notes.
Other current news items
Distribution Agreement for Menoflavon® in JordanPosted on: Tuesday, May 25, 2010
Kudos™ Licensing Agreement
Posted on: Friday, May 14, 2010
Distribution Agreement for Menoflavon® in Singapore
Posted on: Thursday, April 15, 2010
Meldex International PLC 2008 Financial Statements
Posted on: Thursday, January 07, 2010
Announcement: Execution of Memorandum of Understanding
Posted on: Tuesday, December 08, 2009
Distribution Agreement for Menoflavon® in the Netherlands
Posted on: Tuesday, November 03, 2009
Restoration of Registrar Services
Posted on: Thursday, October 15, 2009
Company Update
Posted on: Tuesday, October 13, 2009
Distribution Agreement for Menoflavon® in Canada
Posted on: Friday, October 02, 2009
Company Update
Posted on: Friday, September 25, 2009
Distribution Agreement for Menoflavon® in Austria
Posted on: Friday, September 18, 2009
Update on the Secured Loan Note Offer
Posted on: Wednesday, September 02, 2009
Result of Annual General Meeting
Posted on: Friday, August 28, 2009
Distribution Agreement for Menoflavon® and Melprotect® in United Arab Emirates
Posted on: Monday, August 24, 2009
Secured Loan Note Update and Notice of AGM
Posted on: Wednesday, August 05, 2009
Extension to Secured Loan Note offer deadline
Posted on: Wednesday, July 22, 2009
Appointment of Consultant Project Manager
Posted on: Thursday, July 16, 2009
Distribution Agreement for Menoflavon® in Germany
Posted on: Friday, July 10, 2009
Appointment of Consultant Project Manager
Posted on: Friday, July 10, 2009
Proceedings issued against former Directors
Posted on: Saturday, July 04, 2009
Collaboration Agreement for Meltums™ Pharma Development
Posted on: Thursday, July 02, 2009
Secured Loan Note Applications
Posted on: Wednesday, July 01, 2009
Menoflavon® Distribution Agreements
Posted on: Monday, June 29, 2009
Launch of Secured Loan Note Offer
Posted on: Thursday, June 25, 2009
Distribution Agreement for Menoflavon® in Belgium
Posted on: Wednesday, June 24, 2009
Company Update
Posted on: Monday, June 15, 2009
Product Availability Matrix
Posted on: Thursday, June 11, 2009
Cancellation of Share Options
Posted on: Wednesday, June 03, 2009
Oradisc™ Benzocaine now at Regulatory stage
Posted on: Tuesday, May 05, 2009
Hintz Joint Venture announcement
Posted on: Thursday, April 09, 2009

